Skip to main content

Table 1 Comparison of the demographic and laboratory data in control and patient groups

From: Relationship between circulating microparticles and hypertension and other cardiac disease biomarkers in the elderly

 

Control group

(N = 47)

Patient group

(N = 47)

 

Age (years)

71.6 ± 9.1

72.7 ± 7.2

= 0.5160

Gender (M/F)

19/28

15/32

= 0.3910

ALT (U/L)

18 (14–22)

16 (13–21)

= 0.3040

GGT (U/L)

20 (15–35)

19 (15–32)

= 0.6270

CRP (mg/L)

4.09 (1.83–7.76)

5.20 (2.39–10.80)

= 0.3100

WBC (×10^9/L)

7.2 ± 2.0

7.4 ± 2.0

= 0.6120

Neutrophyl (×10^9/L)

4.3 ± 1.8

4.5 ± 1.8

= 0.5880

Lymphocyte (×10^9/L)

2.1 ± 0.7

2.1 ± 0.8

= 0.9360

NLR

2.07 (1.34–2.81)

2.13 (1.41–3.09)

= 0.5010

PLT (×10^9/L)

216.9 ± 57.4

247.2 ± 64.7

= 0.0250

PDW (fL)

11.5 (11.0–13.3)

11.7 (10.9–13.3)

= 0.8050

MPV (fL)

10.5 ± 0.9

10.3 ± 0.8

= 0.4810

PCT (%)

0.23 (0.21–0.25)

0.26 (0.20–0.28)

= 0.1650

MPslag time (min)

12.87 (10.33–15.67)

12.00 (10.67–14.00)

= 0.5960

MPs ETP (nmol/L•min)

2092.8 ± 676.1

2029.5 ± 615.9

= 0.6450

MPsPeak (nmol/L)

377.43 (294.73–463.98)

388.27 (315.29–473.32)

= 0.5040

MPsttPeak (min)

15.67 (13.00–19.21)

14.44 (13.00–16.38)

= 0.2700

MPsstartTail (min)

31 (28–35)

30 (27–33)

= 0.2730

  1. Meaningful difference was found for only PLT between patient and control groups